HIGHLIGHTS
SUMMARY
In Japan, SARS-CoV-2 mRNA_vaccination began in February 2021, and more than 70% of the population had been vaccinated at least twice by the end of 2021. In Japan, the two most commonly used mRNA_vaccines for COVID-19 are the BNT162b2 mRNA_vaccine (BioNTech and Pfizer) and the mRNA-1273 vaccine (Moderna and Takeda). Few reports have followed SARS-CoV-2 antibody titers over time after spontaneous infection following vaccination. The authors will show the relationship between the number of days after the second and third booster doses and antibody titers, as well as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.